The Metabolic Engine - How Scientists Are Exploring a New Path Beyond GLP-1 Weight-Loss Drugs
nutraceuticalspress clippings
Village Voice: The Metabolic Engine - How Scientists Are Exploring a New Path Beyond GLP-1 Weight-Loss DrugsApril 9, 2026
Perriman at Nasdaq
investornutraceuticalsmedicinepress clippingsvideo
Nasdaq: Damien Perriman interview on NCTApril 2, 2026
Transcript: EXOZ investor update - 4Q + full year 2025 @ March 31, 2026
investor
Transcript: EXOZ investor update - 4Q + full year 2025 @ March 31, 2026April 1, 2026
eXoZymes Provides Fourth Quarter and Full Year 2025 Update
press releaseinvestor
eXoZymes Provides Fourth Quarter and Full Year 2025 UpdateMarch 31, 2026
NLR: Why Use Living Cells?
biofuelmedicinepress clippingsscience
NLR: Why Use Living Cells? NLR Is Making Chemicals With Enzymes AloneMarch 26, 2026
Q4 + 2025 investor call
investor
Sign up: EXOZ investor update - 4Q + full year 2025 @ March 31, 2026March 25, 2026
SynBioBeta: Successful pilot scale run
press clippings
SynBioBeta: Successful pilot scale run with Cayman Chemical validates eXoZymes' technology and scalabilityMarch 21, 2026
Business Insider
press clippings
Business Insider: eXoZymes announces validation milestone for its biomanufacturing platformMarch 20, 2026
USA Today: Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes’ Technology and Scalability
press clippings
USA Today: Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes’ Technology and ScalabilityMarch 20, 2026
GEN: eXoZymes’ Cell-Free Biomanufacturing Platform Gets Positive Feedback from Cayman Chemical
press clippings
GEN: eXoZymes’ Cell-Free Biomanufacturing Platform Gets Positive Feedback from Cayman ChemicalMarch 19, 2026
Previous page
Page 1 of 12
Next page